Form 4 for AMRX Amneal Pharmaceuticals, Inc.

Accepted 2022-05-10 00:00:00 ET · period of report 2022-05-08 · accession 0001209191-22-028159 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-05-10	2022-05-08	AMRX	Nark Ted C	Dir	M - OptEx	—	+35.4K	144.2K	+33%	—
D	2022-05-10	2022-05-08	AMRX	Nark Ted C	Dir	M - OptEx	$0.00	-35.4K	0	-100%	$0
D	2022-05-10	2022-05-09	AMRX	Nark Ted C	Dir	A - Grant	$0.00	+80.1K	80.1K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-05-08	M	A	35,406	—	144,190	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2	Derivative	Restricted Stock Units	2022-05-08	M	D	35,406	$0.00	0	D	— · — to —	35,406 Class A Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F2) On May 5, 2021 the reporting person was granted 35,406 restricted stock units vesting on May 8, 2022.
3	Derivative	Restricted Stock Units	2022-05-09	A	A	80,128	$0.00	80,128	D	— · — to —	80,128 Class A Common Stock	(F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) Restricted stock units vest on the later of (i) the day immediately preceding the issuer's first annual meeting of stockholders following the date of grant and (ii) the day immediately following the first anniversary of the date of grant.